---

title: Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
abstract: Formula I (Ia and Ib) compounds wherein (i) Xis N and Xis S, (ii) Xis CRand Xis S, (iii) Xis N and Xis NR, or (iv) Xis CRand Xis O, including stereoisomers, tautomers, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting the delta isoform of PI3K, and for treating disorders mediated by lipid kinases such as inflammation, immunological, and cancer. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
url: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=1&f=G&l=50&d=PALL&S1=08173650&OS=08173650&RS=08173650
owner: Genentech, Inc.
number: 08173650
owner_city: South San Francisco
owner_country: US
publication_date: 20100526
---
